drugset / Trial / NCT02724852

MMR Vaccination Among HIV-infected Adults

NCT02724852

Phase 4 Completed 632 enrolled Chiang Mai University
Non-randomizedParallel-groupOpen-labelPrevention

Summary

This is a prevalence study of protective antibodies to measles, mumps, and rubella (MMR) in HIV-infected adults and HIV-uninfected controls. MMR vaccination were provided to both groups who had no protective antibodies to at least one of the three viruses.

Timeline

Start
2011-07
Primary completion
2013-09
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject MMR vaccine Vaccine 0.5 ml